Year: 2020

Breaking News

BREAKING: HHS’s Top Lawyer Says Pharma’s 340B Contract Pharmacy Actions Are at Odds with the Law

December 31, 2020 Tom Mirga, Editor at Large Views

“Certain manufacturers’ newfound and unilateral refusal to sell [340B] drugs through contract pharmacies is at odds with the structure and intended operation of the [340B] statute,” HHS General Counsel Robert Charrow said in an advisory opinion late today. | Source:

…

BREAKING: HHS Says 340B Discounts Apply to Contract Pharmacies

December 30, 2020 Tom Mirga, Editor at Large Views

Trump Pardons Disgraced 340B Critic

December 23, 2020 Tom Mirga, Editor at Large Views

HRSA Releases 340B Insulin Final Rule Over Health Centers’ Strong Objections

December 22, 2020 Tom Mirga, Editor at Large Views

White House Clears 340B Insulin Final Rule for Publication

December 18, 2020 Tom Mirga, Editor at Large Views

Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021

December 17, 2020 Tom Mirga, Editor at Large Views

Drug manufacturer vendor Kalderos says it expects several companies to begin using its 340B Pay platform during the next three months.

Kalderos Expects its 340B Rebate Model

…

The New York Times, Often a Public Policy Shaper, Runs Article on 340B Pricing Denials

December 16, 2020 Tom Mirga, Editor at Large Views

Providers Are Pleased, PhRMA Isn’t, With Becerra and State AGs’ 340B Letter to Azar

December 15, 2020 Tom Mirga, Editor at Large Views

Editor’s note—A cascade of breaking 340B news developments over the past seven days—Amgen’s orphan drug action, HRSA’s dispute resolution final rule, the hospital lawsuit against HHS, the state attorneys general letter to HHS and the new GAO report—forced us to

…